Average Co-Inventor Count = 1.30
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Medicenna Therapeutics, Inc. (10 from 10 patents)
2. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,539 patents)
10 patents:
1. 12404497 - Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof
2. 12338269 - IL-2 superagonists in combination with anti-PD-1 antibodies
3. 12274735 - IL-4-fusion formulations for treatment of central nervous system (CNS) tumors
4. 11680090 - Interleukin-2 fusion proteins and uses thereof
5. 11542312 - IL-2 superagonists in combination with anti-PD-1 antibodies
6. 11352402 - Interleukin-4 receptor-binding fusion proteins and uses thereof
7. 11084856 - Interleukin-4 receptor-binding fusion proteins and uses thereof
8. 10781242 - Interleukin-2 fusion proteins and uses thereof
9. 10106592 - Interleukin-4 receptor-binding fusion proteins and uses thereof
10. 10093708 - Interleukin-4 receptor-binding fusion proteins and uses thereof